Tff Pharmaceuticals Inc (TFFP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,414 | 33,795 | 44,716 | 52,067 | 58,055 |
| Receivables | 2,945 | 2,595 | 1,943 | 1,421 | N/A |
| TOTAL | $31,524 | $38,838 | $47,492 | $55,457 | $59,776 |
| Non-Current Assets | |||||
| PPE Net | 2,259 | 1,860 | 1,810 | 1,697 | 1,577 |
| TOTAL | $2,259 | $1,860 | $1,810 | $1,697 | $1,577 |
| Total Assets | $33,783 | $40,698 | $49,302 | $57,154 | $61,354 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,029 | 1,494 | 1,558 | 1,509 | 1,817 |
| Accrued Expenses | N/A | 417 | N/A | N/A | N/A |
| TOTAL | $2,197 | $1,961 | $1,558 | $1,534 | $1,817 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 168 | 50 | N/A | 25 | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,197 | $1,961 | $1,558 | $1,534 | $1,817 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,015 | 1,015 | 1,015 | 1,015 | 1,015 |
| Common Shares | 25 | 25 | 25 | 25 | 25 |
| Retained earnings | -73,694 | -65,318 | -55,269 | -46,590 | -41,934 |
| Other shareholders' equity | -2 | -49 | -170 | -117 | -90 |
| TOTAL | $31,586 | $38,737 | $47,745 | $55,620 | $59,537 |
| Total Liabilities And Equity | $33,783 | $40,698 | $49,302 | $57,154 | $61,354 |